Sibylla Biotech Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 42

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 10

Sibylla Biotech General Information

Description

Developer of patent-based software designed to apply algorithms and drug design protocols. The company's software focuses on drug discovery protocols based on original reaction path sampling and data reduction algorithms to avoid folding and thus bring the protein to degradation, enabling medical practitioners with ways to rationalize drug discovery research for the treatment of incurable diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Piazzetta Chiavica 2
  • 37121 Verona
  • Italy
+39 347
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • Piazzetta Chiavica 2
  • 37121 Verona
  • Italy
+39 347

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sibylla Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC Completed Clinical Trials - General
3. Later Stage VC (Series A) 04-Oct-2022 Completed Clinical Trials - General
2. Seed Round 01-Jul-2019 $2.71M $2.71M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Sibylla Biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Sibylla Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of patent-based software designed to apply algorithms and drug design protocols. The company's software focuse
Biotechnology
Verona, Italy
42 As of 2026

Rochester, NY
 

Warminster, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sibylla Biotech Competitors (10)

One of Sibylla Biotech’s 10 competitors is OyaGen, a Venture Capital-Backed company based in Rochester, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OyaGen Venture Capital-Backed Rochester, NY
Arbutus Biopharma Corporation Warminster, PA
Cytodyn Formerly Angel backed Vancouver, WA
Naicons Accelerator/Incubator Backed Saronno, Italy
ENYO Pharma Venture Capital-Backed Lyon, France
You’re viewing 5 of 10 competitors. Get the full list »

Sibylla Biotech Patents

Sibylla Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4725942-A1 Compounds active on cyclin d1 pathway and their use Pending 09-Oct-2024
WO-2026078558-A1 Compounds active on cyclin d1 pathway and their use Pending 09-Oct-2024
AU-2024375840-A1 Co-translational protein folding simulations Pending 10-Nov-2023
EP-4805940-A1 Co-translational protein folding simulations Pending 10-Nov-2023
WO-2025099240-A1 Co-translational protein folding simulations Inactive 10-Nov-2023 G16B15/30
To view Sibylla Biotech’s complete patent history, request access »

Sibylla Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sibylla Biotech Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
3B Future Health Fund Venture Capital Minority
CDP Venture Capital (Rome) Venture Capital Minority
Claris Ventures Venture Capital Minority
Indaco Venture Partners Venture Capital Minority
Seroba Life Sciences Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Sibylla Biotech FAQs

  • When was Sibylla Biotech founded?

    Sibylla Biotech was founded in 2017.

  • Where is Sibylla Biotech headquartered?

    Sibylla Biotech is headquartered in Verona, Italy.

  • What is the size of Sibylla Biotech?

    Sibylla Biotech has 42 total employees.

  • What industry is Sibylla Biotech in?

    Sibylla Biotech’s primary industry is Biotechnology.

  • Is Sibylla Biotech a private or public company?

    Sibylla Biotech is a Private company.

  • What is Sibylla Biotech’s current revenue?

    The current revenue for Sibylla Biotech is .

  • How much funding has Sibylla Biotech raised over time?

    Sibylla Biotech has raised $25.5M.

  • Who are Sibylla Biotech’s investors?

    3B Future Health Fund, CDP Venture Capital (Rome), Claris Ventures, Indaco Venture Partners, and Seroba Life Sciences are 5 of 10 investors who have invested in Sibylla Biotech.

  • Who are Sibylla Biotech’s competitors?

    OyaGen, Arbutus Biopharma, Cytodyn, Naicons, and ENYO Pharma are some of the 10 competitors of Sibylla Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process